Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2025ACS Applied Bio Materials

Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to Bedside

View Full Paper
Ask AI
Bookmark
Share

Authors

RVRavindra VasaveRBRohit BhawaleOKOmar Khan

Discussion

Loading...

Member takes

Overview

Review details how exosomes serve as drug delivery systems in cancer, highlighting recent advancements in targeting and theranostics.

Key Points

  • Extracellular vesicles, particularly exosomes, are emerging as effective nanocarriers for cancer drug delivery.
  • Surface modifications using targeting ligands can improve the specificity and efficiency of exosome-based therapies.
  • The study emphasizes the role of biomarkers in exosomes for enhancing drug delivery in cancer management.
  • Recent advancements in patents and clinical trials strengthen the use of exosomes in theranostic applications for cancer.

Cite This Study

Vasave et al. (2025) studied this question.

synapsesocial.com/papers/689a093fe6551bb0af8ceb89https://doi.org/10.1021/acsabm.5c00955
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Engineered and Targeted Exosomes for Cancer Therapy: Recent Preclinical Advances2025
  2. 2Exosomes as Emerging Nanocarriers for Targeted Cancer Therapy2026 · 4 citations
  3. 3Exosome Engineering for Targeted Therapy: Tools and Techniques2026
  4. 4Exosomal nanocarriers for targeted drug delivery in cancer therapy2026 · 2 citations
  5. 5The updated role of exosomes in cancer diagnosis and therapy2026